Observational study of PCI in patients with complex coronary atherosclerotic heart disease in the real world

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000034876

Enrollment

Unknown

Registered

2020-07-22

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerotic heart disease

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Coronary heart disease patients undergoing elective PCI; (2) The patient is over 20 years old; (3) Patients were followed up after treatment with complete data; (4) Patients give informed consent to treatment and trial, and sign written "informed consent".

Exclusion criteria

Exclusion criteria: (1) Patients with coronary heart disease treated by emergency PCI; (2) Patients with concurrent pregnancy; (3) Those who have participated in other clinical trials in nearly three months.

Design outcomes

Primary

Measure	Time frame
The incidence of major adverse cardiovascular events (MACE) ;	—

Secondary

Measure	Time frame
The improvement of quality of life (SF-12 scale), symptom improvement (New York heart function classification, Seattle scale, RDS scale) and bleeding events in all enrolled patients after PCI.;	—

Countries

China

Contacts

Public ContactChengxiang Li, Kun Lian

Department of Cardiology, Xijing Hospital, Air Force Medical University

lichx1@163.com+86 13992816228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026